View in browser

Issue 1 - January, 2015                                                               Follow us on Twitter!  @UCSF_Catalyst

In This Issue:

  • UCSF-CTSI Catalyst News
  • Update on Past Catalyst Awardees
  • Translational Research Funding Opportunities
  • Upcoming Events
  • Launchpad-Keys to Success

Catalyst Awards News 

  • Catalyst partnership with MedImmune, Inc was selected as a notable academic-pharma alliance of 2014 by FierceBiotech.  MedImmune will support UCSF’s Catalyst Awards program through funding promising translational projects in the therapeutic areas of interest to MedImmune. 
  • The Partnership between UCSF & Quest Diagnostics, initiated by Catalyst, launched two joint projects in 2014. Projects are aimed at creating a care delivery value chain pathway, focused on diagnostics and outcome measures, in two disease states:  dementia (PI Bruce Miller, MD) and glioma (PIs Susan Chang, MD and Sarah Nelson, PhD). The projects uniquely leverage the leading clinical expertise of UCSF and Quest’s unparalleled logistics network of patients and providers to develop, validate and disseminate the care pathways to the physicians’ offices across the US. See presentation of UCSF-Quest Dementia project at Partnering for Cures 2014. Read More
  • California Healthline featured the prominent role played by Catalyst and QB3 as health care accelerators in the Bay Area. Since its inception in 2010, Catalyst has supported more than 100 technologies through funding, one-on-one consultation and partnerships with business consultants. 
  • University of California – Center for Accelerated Innovation (UC-CAI), one of three national centers funded by NHLBI to accelerate translation of lab innovations to improve public health, ran its inaugural awards cycle in 2014, funding 4 projects across the 5 participating UC medical campuses. Two proposals by  UCSF investigators – Charles Chiu, MD PhD (Dept. Laboratory Medicine) and Stephen Nishimura, MD (Dept. Pathology) received support, highlighting UCSF’s strength in translational research. Read More.

Moving Towards the Clinic: an Update on Past Catalyst Awardees: 

Katherine Possin, PhD, Assistant Professor in the Department of Neurology, was a Catalyst awardee in the Digital Health track in the Spring 2013, with a project aimed to develop a tablet-based cognitive assessment tool (TabCAT) for early assessment of cognitive impairment in older adults.  With high accuracy and ease of administration, TabCAT has the potential to detect signs of cognitive impairment in patients early, leading to most appropriate follow-up diagnostic tests and intervention.
    The Catalyst program has provided guidance to Dr. Possin on how to structure the modular framework of TabCAT and how to best articulate its value to collaborators and funding agencies.  Dr. Possin is now entering into a partnership with Quest Diagnostics to validate TabCAT as a key screening tool in the dementia care pathway and to disseminate it to the primary care providers across the country.

Translational Research Funding Opportunities

  • UC Center for Accelerated Innovation â€“ Health conditions within NIH NHLBI disease domains (heart, blood, lung and sleep) - (up to $200K) pre-apps due Jan 23rd
  • Pfizer’s Centers for Therapeutic Innovation: funding early-stage, large and small molecule projects related to inflammation, autoimmunity, tissue remodeling, oncology, cancer immunology, rare or genetic diseases, neuroscience, cardiovascular and metabolic diseases (pre-application due Feb 13th). For more info contact 
  • UCSF Catalyst Spring 2015 Cycle (up to $100k) Due Feb 23rd 
  • AACR / Breast Cancer – discovery, development, and application of new agents to treat breast cancer and/or for pre-clinical research with direct therapeutic intent (up to $138k) Due Jan 20th
  • The Biomarker Factory – funding of biomarker projects in all stages from early discovery to validation studies (up to $800k) rolling deadline
  • NIH SBIR/STTR grants (up to $1M) Due Apr 5th
  • Alzheimer’s Drug Discovery Foundation: preclinical drug discovery and biomarker Development (up to $150K) Due Mar 10th
  • Bayer Grants4targets – Novel drug targets and biomarkers (up to €125k) Due Mar 3rd 
  • Taubman Prize for Excellence in Translational Medical Science (Prize total: $100k) Due Feb 1st

Upcoming Events

  • QED@QB3: "How to Solve Immigration Issues Faced by Entrepreneurs" by Norman Plotkin and Atessa Chehrazi. Tuesday, Jan 27th, 12:00 PM - tickets
  • Entrepreneurship Center Speaker Series: “Accountable Innovation: New Strategies for Medtech” by Paul Yock. Wednesday, Jan 28th 5:30PM - tickets  
  • "Translational Research: The Value of Studying Outliers. Lessons from Scorpions, Rats, Patients and Healthy People", by Hal Barron, MD. Friday, Jan 30th, 11:00 AM to 12:00 PM – Mission Bay, Genentech Hall, Byers Auditorium (GH 106). Open to Public, RSVP by Jan 23rd 
  • QED@QB3: "Best Practices in Taxes and Accounting for Startups" by Ryan Fischesser, Brent Hillberg and Robbie Lewis. Tuesday, Feb 3rd, 2:00 PM - tickets  
  • QB3 Spring 2015 SBIR Workshop – Wednesdays 1:30 PM to 3:30PM, Feb 4th - Apr 1st registration
  • “The Innovation Imperative: An Insider's Perspective on Radical Disruption Within the Biotech Industry” by Ashley Dombkowski, PhD. A venture capitalist's view of the 2015 JPMorgan Healthcare Conference and Biotech – Weds, Jan 21st, 5:30 PM – registration   
  • Personalized Medicine World Conference (PMWC) - Mountain View - Jan 26th-28th  â€“ Session themes such as: Consumerism & Crowdsourcing, Coverage & Reimbursement, Applying Complimentary Technologies Towards Biomarker Discovery, Large Sequence Data Analysis & Clinical Interpretation, Pharma Perspective on PM, Risk-Reward & Innovation registration  
  • CALBIO2015 â€““Turning Challenges into Opportunities” - Two-day statewide industry event attracts the world’s leading life science and pharmaceutical companies, investment funds, patient foundations and university technology transfer offices - Mar 2nd & 3rd - registration
Pres of R&D at Calico
Hal Barron, MD to speak on 
Translational Research
Fri 11am-12pm 
UCSF Mission Bay 
Byers Aud GH -106
Open to public
RSVP by Sept 23rd

UCSF Catalyst Awards
Spring 2015 Cycle

Application period
Jan 26-Feb 23rd
CALBIO2015 â€“
“Turning Challenges into Opportunities”

Panel on pharma-academia collaborations

Launchpad -
Keys to Success

Check out the latest video 'How to Identify a Commercial Partner' w/ Cook Medical on
UCSF Profiles
Search, Discover, Network

UCSF Cores Search
Equipment & Services for Researchers

UCSF Open Proposals

Enabling Proposal & Team Development
Help us support your research. Please cite our grant in all publications supported by CTSI, and comply with NIH Public Access Policy.
CTSI Research Navigation Services
Get help finding research resources and information.
UCSF-CTSI Catalyst Awards Program
University of California, San Francisco (UCSF)
CTSI, Box 0558
550 16th Street (at corner of 4th St.)
6th Floor, San Francisco, CA 94158

Catalyst Awards Program | Early Translational Research | UCSF Profiles

Stay up to date with the Catalyst Team via Twitter, Flickr or email!